Does METOPROLOL Cause Disseminated intravascular coagulation? 16 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Disseminated intravascular coagulation have been filed in association with METOPROLOL (metoprolol succinate). This represents 0.0% of all adverse event reports for METOPROLOL.
16
Reports of Disseminated intravascular coagulation with METOPROLOL
0.0%
of all METOPROLOL reports
9
Deaths
12
Hospitalizations
How Dangerous Is Disseminated intravascular coagulation From METOPROLOL?
Of the 16 reports, 9 (56.3%) resulted in death, 12 (75.0%) required hospitalization, and 10 (62.5%) were considered life-threatening.
Is Disseminated intravascular coagulation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METOPROLOL. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does METOPROLOL Cause?
Drug ineffective (3,434)
Dyspnoea (3,428)
Dizziness (3,275)
Hypotension (3,213)
Completed suicide (2,959)
Fatigue (2,784)
Off label use (2,580)
Toxicity to various agents (2,404)
Bradycardia (2,024)
Nausea (1,894)
What Other Drugs Cause Disseminated intravascular coagulation?
PREDNISOLONE (362)
METHOTREXATE (347)
DEXAMETHASONE (323)
METHYLPREDNISOLONE (307)
NIVOLUMAB (305)
CYCLOPHOSPHAMIDE (286)
TACROLIMUS (278)
PREDNISONE (277)
VINCRISTINE (245)
OXALIPLATIN (231)
Which METOPROLOL Alternatives Have Lower Disseminated intravascular coagulation Risk?
METOPROLOL vs METRELEPTIN
METOPROLOL vs METRONIDAZOLE
METOPROLOL vs METRONIDAZOLE\METRONIDAZOLE
METOPROLOL vs METYRAPONE
METOPROLOL vs MEXILETINE